TVTX: Travere Therapeutics, Inc.
Performance
TVTX +59.65%
Watchlist
Select an item
Summary
TVTX at a glance
TVTX returned +59.65% over the past year and +11.36% a year over five years. Its worst drop in that year was -33.49%, smaller than 50% of stocks on Redstone, and its Sharpe ratio of 0.98 beats 74% of stocks on Redstone. It pays no dividends.
Current Drawdown
-23.53%
Rolling Volatility
48.12%
Actions
Metrics
Risk Indicators
Alpha48.15%
Beta1.39x
Sharpe0.98
Sortino1.78
Omega1.22
Calmar1.78
Martin3.83
Profile
About TVTX
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $5.0B
- Listed
- Jul 2003
- Employees
- 497
- Headquarters
- San Diego, CA
- Website
- travere.com
Comparisons